Clinical Trial Update: AGS-1C4D4 in Patients With Advanced Hormone Refractory Prostate Cancer [Phase 1]

View source ↗

Summary

A Phase 1 trial update of AGS-1C4D4 in patients with advanced hormone-refractory prostate cancer has been completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Prostate Cancer

Drugs mentioned

• AGS-1C4D4

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Prostate Cancer | Phase 1 | Status: COMPLETED